Federico Grossi insider trades

Open-market stock purchases and sales by Federico Grossi, Chief Medical Officer at Unity Biotechnology, Inc, from SEC Form 4 filings since Feb 16, 2018.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • UBX Unity Biotechnology, Inc: other filings, last Jan 6, 2025
  • APLS Apellis Pharmaceuticals, Inc: 42 sales, last Jan 5, 2023

Get free alerts when Federico Grossi files a new trade →